Results 91 to 100 of about 455 (133)

A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of An Orally Administered Drug Product: From IVIVC to IVIVP

open access: yes, 2019
The application of in silico modeling to predict the in vivo outcome of an oral drug product is gaining a lot of interest. Fully relying on these models as a surrogate tool requires continuous optimization and validation. To do so, intraluminal and systemic data are desirable to judge the predicted outcomes.
openaire   +2 more sources

A review of OSP suite PBBM capabilities: looking ahead

open access: yesA review of OSP suite PBBM capabilities: looking ahead
Stephan Schaller   +3 more
openaire   +1 more source

Impact of gastric mixing and water intake on postprandial pharmacokinetics of orally disintegrating tablets: A PBBM-based study

open access: yesEuropean Journal of Pharmaceutics and Biopharmaceutics
Yoshinori Takahashi   +3 more
openaire   +1 more source

Physiologically Based Pharmacokinetic Modeling of Efavirenz Nanoparticles: from Animal Model to Human Extrapolation. [PDF]

open access: yesACS Omega
da Silva TM   +8 more
europepmc   +1 more source

Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and its Regulatory Utility to Support Oral Drug Product Development and Harmonization. [PDF]

open access: yesPharm Res
Cheng YH   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy